104,614,219 Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9-MAY-2026. These Common Stock will be under lockup for 16 days starting from 23-APR-2026 to 9-MAY-2026.
Details:
The officers and directors have agreed with the placement agent to be subject to a lock-up period of 15 days following the date of this prospectus supplement. This means that, during the applicable lock-up period, we may not offer for sale, contract to sell, or sell any shares of common stock or any securities convertible into, or exercisable or exchangeable for, shares of common stock subject to certain customary exception such as issuing stock options to directors, officers, employees and consultants under existing plans.